FAK overexpression and p53 mutations are highly correlated in human breast cancer

International Journal of Cancer

Volumn 125, Issue 7, 2009, Pages 1735-1738

  Golubovskaya, Vita M ^a   Conway Dorsey, Kathleen ^b,c   Edmiston, Sharon N ^b,c   Tse, Chiu Kit ^b,c   Lark, Amy A ^d   Livasy, Chad A ^e   Moore, Dominic ^c,f   Millikan, Robert C ^b,c   Cance, William G ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b IL   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f University of North Carolina at Chapel Hill   (United States)

Author keywords

Breast cancer; Focal adhesion kinase; p53; Tumor

Indexed keywords

FOCAL ADHESION KINASE; PROTEIN P53;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER STAGING; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RACE; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADULT; AFRICAN AMERICANS; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOCAL ADHESION KINASE 1; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MUTATION; NORTH CAROLINA; REGISTRIES; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 68549133222     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24486     Document Type: Article

References (20)

1. Vogelstein B, Kinzler KW. p53 function and dysfunction. Cell 1992;70:523-6.
2. Giaccia AJ, Kastan MB. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev 1998;12: 2973-83.
3. Golubovskaya V, Kaur A, Cance W. Cloning and characterization of the promoter region of human focal adhesion kinase gene: nuclear factor kappa B and p53 binding sites. Biochim Biophys Acta 2004;1678:111-25.
4. Hanks SK, Ryzhova L, Shin NY, Brabek J. Focal adhesion kinase signaling activities and their implications in the control of cell survival and motility. Front Biosci 2003;8:d982-d96.
5. Lightfoot HM, Lark A, Livasy CA, Moore DT, Cowan D, Dressler L, Craven RJ, Cance WG. Upregulation of focal adhesion kinase (FAK) expression in ductal carcinoma in situ (DCIS) is an early event in breast tumorigenesis. Breast Cancer Res Treat 2004;88: 109-16.
6. Cance WG, Harris JE, Iacocca MV, Roche E, Yang X, Chang J, Simkins S, Xu L. Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. Clin Cancer Res 2000;6:2417-23.
7. Weiner TM, Liu ET, Craven RJ, Cance WG. Expression of focal adhesion kinase gene and invasive cancer. Lancet 1993;342:1024-5.
8. Lark AL, Livasy CA, Calvo B, Caskey L, Moore DT, Yang X, Cance W. Overexpression of focal adhesion kinase in primary colorectal carcinomas and colorectal liver metastases: immunohisto-chemistry and real-time PCR analyses. Clin Cancer Res 2003;9: 215-22.
9. Ilic D, Almeida EA, Schlaepfer DD, Dazin P, Aizawa S, Damsky CH. Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis. J Cell Biol 1998; 143:547-60.
10. Golubovskaya VM, Finch R, Cance WG. Direct interaction of the N-terminal domain of focal adhesion kinase with the N-terminal transactivation domain of p53. J Biol Chem 2005;280: 25008-21.
11. Lim ST, Chen XL, Lim Y, Hanson DA, Vo TT, Howerton K, Larocque N, Fisher SJ, Schlaepfer DD, Ilic D. Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation. Mol Cell 2008;29:9-22.
12. Golubovskaya VM, Cance WG. Focal adhesion kinase and p53 signaling in cancer cells. Int Rev Cytol 2007;263:103-53.
13. Cance WG, Golubovskaya VM. Focal adhesion kinase versus p53: apoptosis or survival? Sci Signal 2008;1:pe22.
14. Wei CL, Wu Q, Vega VB, Chiu KP, Ng P, Zhang T, Shahab A, Yong HC, Fu Y, Weng Z, Liu J, Zhao XD, et al. A global map of p53 transcription-factor binding sites in the human genome. Cell 2006;124: 207-19.
15. Golubovskaya VM, Finch R, Kweh F, Massoll NA, Campbell-Thompson M, Wallace MR. Cance WG. p53 regulates FAK expression in human tumor cells. Mol Carcinog 2008;47:373-82.
16. Lark AL, Livasy CA, Dressler L, Moore DT, Millikan RC, Geradts J, Iacocca M, Cowan D, Little D, Craven RJ, Cance W. High focal adhesion kinase expression in invasive breast carcinomas is associated with an aggressive phenotype. Mod Pathol 2005;18: 1289-94.
17. Conway K, Edmiston SN, Cui L, Drouin SS, Pang J, He M, Tse CK, Geradts J, Dressler L, Liu ET, Millikan R, Newman B. Prevalence and spectrum of p53 mutations associated with smoking in breast cancer. Cancer Res 2002;62:1987-95.
18. Livasy CA, Moore D, Cance WG, Lininger RA. Focal adhesion kinase overexpression in endometrial neoplasia. Appl Immunohistochem Mol Morphol 2004;12:342-5.
19. Fukushima T, Onda M, Abe R, Otake T, Kimijima I, Tsuchiya A. p53 mutations and overexpressions in Japanese breast cancer. Eur J Surg Oncol 1995;21:595-600.
20. Lien HC, Lin CW, Mao TL, Kuo SH, Hsiao CH, Huang CS. p53 over-expression and mutation in metaplastic carcinoma of the breast: genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components. J Pathol 2004;204: 131-9.